Groowe Groowe / Newsroom / CAPR
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CAPR News

Capricor Therapeutics Inc

Form 8-K

sec.gov
CAPR

Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

globenewswire.com
CAPR

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Atkore Inc. (ATKR), Axsome Therapeutics, Inc. (AXSM), Capricor Therapeutics, Inc. (CAPR), and CTO Realty Growth, Inc. (CTO)

globenewswire.com
ATKR AXSM CAPR CTO

Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy

globenewswire.com
CAPR

Form 8-K

sec.gov
CAPR

Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA

globenewswire.com
CAPR

Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA

globenewswire.com
CAPR

Local Entrepreneur to Open New Capriotti's Sandwich Shop in Warren on March 10

prnewswire.com
CAPR

Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12

globenewswire.com
CAPR

Exosome Diagnostic and Therapeutics Market to Reach USD 401.70 Million by 2032 Amid Rapid Advances in Liquid Biopsy, Precision Medicine, and Exosome-Based Drug Delivery - Credence Research

prnewswire.com
TMO CAPR